BioCentury
ARTICLE | Clinical News

ACP-SL017: Phase I start

September 5, 2005 7:00 AM UTC

AAF will begin an open-label, dose-escalation, Phase I trial in patients to evaluate ACP-SL017 with and without photoactivation. The company expects to complete the trial before the year end. ...